Valneva shares spike after saying vaccine candidate outperformed AstraZeneca’s
October 18, 2021 at 05:06 AM EDT
Valneva's wild stock-price rise continued on Monday after the French biotech said its coronavirus vaccine candidate outperformed AstraZeneca's in a trial.
